( Researchers have identified a virus tha...)Virus to treat brain tumor,,,Health
Navigation Links
Virus to treat brain tumor,,
Researchers have identified a virus that targets and kills a type of brain tumor.//
A strain of vesicular stomatitis virus (VSV) can successfully target and kill glioblastoma, which is one of the deadliest forms of brain tumors. Glioblastoma is a form of brain tumor that is resistant to modern medical or surgical procedures.
Researchers of Yale School of Medicine had taken nine different DNA and RNA viruses through a series of tests to find out the one which is most effective at killing tumor cells. The successful viruses were cultivated for many generations on brain tumor cells, cloned to have more tumor killing capacities, and capacities lessened to infect non-tumor cells.
The scientists found the VSV strain that can be replicated through their genetic code carried in their RNA. The genetically muted VSV strain had also been created that it cannot replicate itself while affecting the brain tumor cells.
Researchers feel that non-replication may only lead to a few tumor cells being killed. Hence more research is required to make the virus affect the brain tumor cells, replicate itself and kill more tumor cells in the surroundings.
The study was published in the current issue of Journal of Virology.
Reference: Yale School of Medicine, news release, May 2005
'"/>
Related medicine news :
1. Virus Level could Predict Cervical Cancer Risk
2. Ebola Virus - Outbreak Claims More Lives In Uganda.
3. Experimental treatment for Ebola Virus Shows promising results in mice
4. Virus Combats Brain Tumour
5. Virus killer
6. Pain Killers Keep the Virus Away
7. Measles Suppresses AIDS Virus
8. Virus connection to cervical injury
9. Virus Helps Remove Brain Cancer
10. Origin Of SARS Virus Discovered
11. New Molecule that can stop the growth of Viruses
Post Your Comments:
(Date:10/6/2008)... Millions of women suffer with symptoms of men...conomic rescue plan. But the effects of our curren...aking it increasingly difficult for U.S. women to ...kstead announces new cost effective drug-free guid...a prescription. , Las Veg...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: ...ed SAP as senior vice president,of the Healthcare ...e,August 1, 2008, Mr. Papandrea will help drive SA...egic software solutions to healthcare,organization...onjunction,with the 3rd annual Ambassadors Dinner ...
(Date:10/5/2008)...e blood test may help detect serious bacterial inf...lood stream infections in young infants who come t...ave no clear cause. Researchers at Children,s Hosp...eorge Washington University, show that a new diagn...y infants at high risk for SBIs while potentially ...
(Date:10/5/2008)...ittle exercise goes a long way toward helping seve...fe and complete important daily tasks, according t... , In a pre-program assessment where patients re...e per week, individuals who were more active repor...rted improvements in their ability to perform dail...
Breaking Medicine News(10 mins):Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3Health News:New test could help catch serious infections in babies 2Health News:A little exercise goes a long way for severely obese 2...lds of academia, research, government and industry...of-the-art// communications technology can make he...an emerging field that encompasses a range of heal...ectronic medical records, telemedicine, citizen-or...
...the National Rural Health Mission (NHRM) of India ...ogrammes.// The funds will be allocated through U...pecific activities. The governments of India and ...i-partner initiative Tuesday here for achieving th...
...and those affected by HIV/AIDS, a Community Based ...ai Vizhuthugal' (Tamil Nadu AIDS Initiative Roots)...m Coimbatore, Madurai, Vellore, Salem and Chennai,...g the community to undertake and develop skills fo...
...al to expand price control from 74 to 354 drugs in...dustry chamber CII today said the step will prove ...as the economy. "Healthy competition between phar...le pricing. Instead of affecting the growth by ove...
Other Medicine News:Health News:Delhi to Host E-health Global Meet Next Month 2Health News:Norway Grants $80 mn to India's Health Mission 2(Date:10/3/2008)... REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCall/...ed the filing of an investigational new drug,(IND)...molecule modulator,of phosphodiesterase 4 (PDE4), ...e compound is being developed as a new and potenti...y loss and cognitive deficits associated,with Alzh...
(Date:10/2/2008)...The Study Will Compare the Results of Rosetta Geno...hich Differentiates Squamous From non Squamous ...tic Methods, A Test Based on the miRview(TM) Techn...olumbia University,s High Complexity Molecular Pat...Year, Rosetta Genomics is Expecting to Launch miR...
(Date:10/2/2008)... GOTEBORG, Sweden, October 2 /- Calab... dose study in xerostomia ("dry mouth"),patients h...studied in 45,dry mouth patients between the ages ...ct a dose for evaluation in a succeeding Phase III... the cholinesterase inhibitor,physostigmine. It is...
(Date:10/2/2008)... Data Indicate Dual Modes of Action and Synergy ...stCall/ -- Access Pharmaceuticals, Inc.,(OTC Bulle...clinical,studies on Angiolix showing that by block...nic effect as well as a direct anti-proliferative ... of human breast cancer (MX-1),Angiolix had a sig...
Breaking Medicine Technology:deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3Pancreatic Cancer Biomarkers Found 21825 1Pancreatic Cancer Biomarkers Found 21825 2Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 1Specific location of the TRAF1 C5 gene associated with multiple autoimmune diseases 21822 230 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 130 percent RA patients refractory to anti TNFs achieve disease remission with tocilizumab plus metho 21819 2Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 1Disc Motion Technologies Announces First Human Implants of True TSMS 28TM 29 Device 2425 2[0] deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders[0] Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay[0] Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients[0] Access Pharmaceuticals Presents New Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody
...1, 2007 - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), ...alization of cell therapies, made a poster,present... of,Clinical Immunology Societies (FOCIS) in San D...p; Marina. The poster, entitled,"Identifying New I...ng Multiple Sclerosis Patients" was presented on S...
...t Federation of,Clinical Immunology Societies (FOC...007 /PRNewswire-FirstCall/ --,Orchestra Therapeuti...sitive new data from its completed Phase II open-l...ell Receptor (TCR) peptide,vaccine for the treatme... The new data, presented last week at the Federati...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |